Applied Therapeutics (APLT) Short Interest Ratio & Short Volume → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free APLT Stock Alerts $4.40 -0.24 (-5.17%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Applied Therapeutics Short Interest DataCurrent Short Volume4,470,000 sharesPrevious Short Volume4,740,000 sharesChange Vs. Previous Month-5.70%Dollar Volume Sold Short$19.76 millionShort Interest Ratio / Days to Cover2.6Last Record DateApril 30, 2024Outstanding Shares114,270,000 sharesPercentage of Shares Shorted3.91%Today's Trading Volume986,577 sharesAverage Trading Volume1,725,047 sharesToday's Volume Vs. Average57% Short Selling Applied Therapeutics ? Sign up to receive the latest short interest report for Applied Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPLT Short Interest Over TimeAPLT Days to Cover Over TimeAPLT Percentage of Float Shorted Over Time Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. Applied Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,470,000 shares $19.76 million -5.7%N/A2.6 $4.42 4/15/20244,740,000 shares $23.98 million -4.8%N/A2.6 $5.06 3/31/20244,980,000 shares $33.86 million +31.4%N/A2.4 $6.80 3/15/20243,790,000 shares $22.82 million -12.5%N/A1.8 $6.02 2/29/20244,330,000 shares $30.83 million +11.9%N/A1.9 $7.12 2/15/20243,870,000 shares $14.51 million +4.3%N/A2 $3.75 Get the Latest News and Ratings for APLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,710,000 shares $11.61 million +2.2%N/A2.7 $3.13 1/15/20243,630,000 shares $9.08 million +83.3%N/A2.8 $2.50 12/31/20231,980,000 shares $6.63 million -7.5%N/A1.5 $3.35 12/15/20232,140,000 shares $6.33 million -37.1%N/A2.1 $2.96 11/30/20233,400,000 shares $7.17 million +71.7%N/A3.2 $2.11 11/15/20231,980,000 shares $4.22 million +2.6%N/A2 $2.13 10/31/20231,930,000 shares $4.63 million +27.0%N/A2.1 $2.40 10/15/20231,520,000 shares $3.68 million +49.0%N/A1.6 $2.42 9/30/20231,020,000 shares $2.54 million -55.5%N/A1.4 $2.49 9/15/20232,290,000 shares $4.26 million +54.7%N/A3.6 $1.86 8/31/20231,480,000 shares $1.97 million -3.3%N/A3.6 $1.33 8/15/20231,530,000 shares $2.05 million +39.1%N/A6.4 $1.34 7/31/20231,100,000 shares $1.96 million No ChangeN/A4.5 $1.78 7/15/20231,100,000 shares $1.52 million +0.9%N/A2.8 $1.38 6/30/20231,090,000 shares $1.40 million +9.1%N/A2.7 $1.28 6/15/2023999,000 shares $1.43 million +13.5%N/A2.4 $1.43 5/31/2023880,000 shares $1.14 million +48.1%N/A2.2 $1.29 5/15/2023594,400 shares $855,936.00 -18.2%N/A1.5 $1.44 4/30/2023726,400 shares $1.23 million +107.4%N/A1.6 $1.70 4/15/2023350,200 shares $292,767.20 -21.0%N/A1.1 $0.84 3/31/2023443,300 shares $359,560.63 +6.3%N/A1.8 $0.81 3/15/2023417,000 shares $371,130.00 -17.3%N/A1.5 $0.89 2/28/2023504,100 shares $509,141.00 +32.2%N/A1.8 $1.01 2/15/2023381,300 shares $381,300.00 -3.3%N/A1.2 $1.00 1/31/2023394,100 shares $437,451.00 +8.8%N/A1.3 $1.11 1/15/2023362,200 shares $340,468.00 +70.9%N/A1.2 $0.94 12/30/2022211,900 shares $161,044.00 -34.3%N/A0.6 $0.76 12/15/2022322,600 shares $275,823.00 +29.7%N/A0.9 $0.86 11/30/2022248,800 shares $278,656.00 -6.6%N/A0.7 $1.12 11/15/2022266,400 shares $226,120.32 +14.4%N/A0.8 $0.85 10/31/2022232,800 shares $180,187.20 -11.0%N/A0.7 $0.77 10/15/2022261,500 shares $161,084.00 +24.8%N/A0.8 $0.62 9/30/2022209,600 shares $194,948.96 -1.1%N/A0.8 $0.93 9/15/2022212,000 shares $313,760.00 -9.4%N/A0.5 $1.48A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. APLT Short Interest - Frequently Asked Questions What is Applied Therapeutics' current short interest? Short interest is the volume of Applied Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 4,470,000 shares of APLT short. Learn More on Applied Therapeutics' current short interest. What is a good short interest ratio for Applied Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APLT shares currently have a short interest ratio of 3.0. Learn More on Applied Therapeutics's short interest ratio. Which institutional investors are shorting Applied Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Applied Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Applied Therapeutics' short interest increasing or decreasing? Applied Therapeutics saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 4,470,000 shares, a decrease of 5.7% from the previous total of 4,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Applied Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Applied Therapeutics: KalVista Pharmaceuticals, Inc. (13.13%), Y-mAbs Therapeutics, Inc. (7.47%), Verve Therapeutics, Inc. (30.19%), Aerovate Therapeutics, Inc. (10.43%), Astria Therapeutics, Inc. (10.24%), Arbutus Biopharma Co. (3.08%), IGM Biosciences, Inc. (29.87%), Travere Therapeutics, Inc. (16.83%), Altimmune, Inc. (31.47%), Larimar Therapeutics, Inc. (6.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Applied Therapeutics stock? Short selling APLT is an investing strategy that aims to generate trading profit from Applied Therapeutics as its price is falling. APLT shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Applied Therapeutics? A short squeeze for Applied Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APLT, which in turn drives the price of the stock up even further. How often is Applied Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APLT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: KalVista Pharmaceuticals Short Interest Y-mAbs Therapeutics Short Interest Verve Therapeutics Short Interest Aerovate Therapeutics Short Interest Astria Therapeutics Short Interest Arbutus Biopharma Short Interest IGM Biosciences Short Interest Travere Therapeutics Short Interest Altimmune Short Interest Larimar Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APLT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsThis unknown company solves the biggest issue with AIManward PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange